• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.NDRG1将p53与增殖介导的中心体稳态和基因组稳定性联系起来。
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11583-8. doi: 10.1073/pnas.1503683112. Epub 2015 Aug 31.
2
The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.转移抑制因子,N-myc 下游调节基因 1(NDRG1),通过非依赖 p53 的机制上调 p21。
Carcinogenesis. 2011 May;32(5):732-40. doi: 10.1093/carcin/bgr046. Epub 2011 Mar 11.
3
Genomic instability and apoptosis are frequent in p53 deficient young mice.基因组不稳定和细胞凋亡在p53基因缺陷的幼鼠中很常见。
Oncogene. 1997 Sep;15(11):1295-302. doi: 10.1038/sj.onc.1201482.
4
NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.NDRG1 下调 ATF3 并抑制肺癌 A549 细胞中的顺铂细胞毒性。
Int J Med Sci. 2018 Oct 20;15(13):1502-1507. doi: 10.7150/ijms.28055. eCollection 2018.
5
Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle.NDRG1 的磷酸化在细胞周期中具有时间和空间上的控制。
Biochem Biophys Res Commun. 2011 Jul 29;411(2):227-34. doi: 10.1016/j.bbrc.2011.06.092. Epub 2011 Jun 17.
6
N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.N- myc下游调控基因1在卵巢癌中起肿瘤抑制作用。
Oncol Rep. 2014 May;31(5):2279-85. doi: 10.3892/or.2014.3072. Epub 2014 Mar 11.
7
N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.N-myc 下游调节基因 1/Cap43 过表达通过使肝癌细胞周期停滞在 G0/G1 期来抑制肿瘤生长。
Cancer Lett. 2011 Nov 1;310(1):25-34. doi: 10.1016/j.canlet.2011.05.034. Epub 2011 Jun 24.
8
Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.p53“热点”突变体之间中心体复制调控活性的差异:p53的Ser 315磷酸化依赖性中心体结合的潜在作用。
Oncogene. 2001 Oct 18;20(47):6851-63. doi: 10.1038/sj.onc.1204848.
9
Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.p53突变和细胞周期蛋白E过表达诱导人膀胱癌细胞中心体扩增和染色体不稳定
Cancer Res. 2004 Jul 15;64(14):4800-9. doi: 10.1158/0008-5472.CAN-03-3908.
10
[Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].[NDRG1的过表达:与乳腺癌细胞系的增殖活性、侵袭性及乳腺癌转移的关系]
Zhonghua Bing Li Xue Za Zhi. 2006 Jun;35(6):333-8.

引用本文的文献

1
Insight into the Regulation of NDRG1 Expression.深入了解NDRG1表达的调控机制。
Int J Mol Sci. 2025 Apr 10;26(8):3582. doi: 10.3390/ijms26083582.
2
Protecting centrosomes from fracturing enables efficient cell navigation.保护中心体不发生断裂可实现高效的细胞导航。
Sci Adv. 2025 Apr 25;11(17):eadx4047. doi: 10.1126/sciadv.adx4047.
3
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine.使用mTORC2导向的RNAi纳米药物诱导三阴性乳腺癌细胞死亡和化疗敏感性
Cancer Res Commun. 2025 Mar 1;5(3):458-476. doi: 10.1158/2767-9764.CRC-24-0261.
4
Hepatoprotective Activity of Nature-Derived Polyphenols Studied by Mass Spectrometry Based Multi-OMICS Approach.基于质谱的多组学方法研究天然来源多酚的肝保护活性
Int J Mol Sci. 2025 Feb 13;26(4):1604. doi: 10.3390/ijms26041604.
5
Mutational disparities in colorectal cancers of White Americans, Alabama African Americans, And Oklahoma American Indians.美国白人、阿拉巴马非裔美国人及俄克拉荷马美洲印第安人大肠癌的突变差异
NPJ Precis Oncol. 2024 Dec 23;8(1):288. doi: 10.1038/s41698-024-00782-9.
6
Germline variant affecting p53β isoforms predisposes to familial cancer.胚系变异影响 p53β 异构体,易患家族性癌症。
Nat Commun. 2024 Sep 18;15(1):8208. doi: 10.1038/s41467-024-52551-8.
7
Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer.磷酸化 HDAC6 的相分离驱动三阴性乳腺癌中染色质结构的异常。
Nat Cancer. 2024 Nov;5(11):1622-1640. doi: 10.1038/s43018-024-00816-y. Epub 2024 Aug 28.
8
NDRGs in Breast Cancer: A Review and In Silico Analysis.乳腺癌中的疾病诊断相关分组:综述与计算机模拟分析
Cancers (Basel). 2024 Mar 29;16(7):1342. doi: 10.3390/cancers16071342.
9
N-myc downstream regulated gene 1 inhibition of tumor progression in Caco2 cells.N- myc下游调控基因1对Caco2细胞肿瘤进展的抑制作用
World J Gastrointest Oncol. 2022 Dec 15;14(12):2313-2328. doi: 10.4251/wjgo.v14.i12.2313.
10
HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells.HOXA5 通过稳定 IκBα 抑制 NF-κB 通路并抑制乳腺上皮细胞的恶性转化。
Cancer Res. 2022 Oct 17;82(20):3802-3814. doi: 10.1158/0008-5472.CAN-21-4277.

本文引用的文献

1
The butterfly effect in cancer: a single base mutation can remodel the cell.癌症中的蝴蝶效应:单个碱基突变就能重塑细胞。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1131-6. doi: 10.1073/pnas.1424012112. Epub 2015 Jan 12.
2
Mutant p53 in cancer: new functions and therapeutic opportunities.癌症中突变型 p53:新功能与治疗机会。
Cancer Cell. 2014 Mar 17;25(3):304-17. doi: 10.1016/j.ccr.2014.01.021.
3
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.利用 cBioPortal 进行复杂癌症基因组学和临床特征的综合分析
Sci Signal. 2013 Apr 2;6(269):pl1. doi: 10.1126/scisignal.2004088.
4
Gene copy-number alterations: a cost-benefit analysis.基因拷贝数改变:成本效益分析。
Cell. 2013 Jan 31;152(3):394-405. doi: 10.1016/j.cell.2012.11.043.
5
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
6
Mutant p53: one name, many proteins.突变型 p53:一个名字,多种蛋白。
Genes Dev. 2012 Jun 15;26(12):1268-86. doi: 10.1101/gad.190678.112.
7
Losing balance: the origin and impact of aneuploidy in cancer.失去平衡:癌症中非整倍体的起源和影响。
EMBO Rep. 2012 Jun 1;13(6):501-14. doi: 10.1038/embor.2012.55.
8
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.单一等位基因的癌症易感性基因 BRCA1 的突变导致人类乳腺上皮细胞的基因组不稳定。
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17773-8. doi: 10.1073/pnas.1110969108. Epub 2011 Oct 10.
9
Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response.p53 基因缺失导致人乳腺上皮细胞染色体不稳定和治疗反应改变。
Oncogene. 2010 Aug 19;29(33):4715-24. doi: 10.1038/onc.2010.220. Epub 2010 Jun 21.
10
A mechanism linking extra centrosomes to chromosomal instability.一种将额外中心体与染色体不稳定性相联系的机制。
Nature. 2009 Jul 9;460(7252):278-82. doi: 10.1038/nature08136. Epub 2009 Jun 7.

NDRG1将p53与增殖介导的中心体稳态和基因组稳定性联系起来。

NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.

作者信息

Croessmann Sarah, Wong Hong Yuen, Zabransky Daniel J, Chu David, Mendonca Janet, Sharma Anup, Mohseni Morassa, Rosen D Marc, Scharpf Robert B, Cidado Justin, Cochran Rory L, Parsons Heather A, Dalton W Brian, Erlanger Bracha, Button Berry, Cravero Karen, Kyker-Snowman Kelly, Beaver Julia A, Kachhap Sushant, Hurley Paula J, Lauring Josh, Park Ben Ho

机构信息

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287;

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Chemical and Biomolecular Engineering, The Whiting School of Engineering, Johns Hopkins University, Baltimore, MD 21218

出版信息

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11583-8. doi: 10.1073/pnas.1503683112. Epub 2015 Aug 31.

DOI:10.1073/pnas.1503683112
PMID:26324937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4577188/
Abstract

The tumor protein 53 (TP53) tumor suppressor gene is the most frequently somatically altered gene in human cancers. Here we show expression of N-Myc down-regulated gene 1 (NDRG1) is induced by p53 during physiologic low proliferative states, and mediates centrosome homeostasis, thus maintaining genome stability. When placed in physiologic low-proliferating conditions, human TP53 null cells fail to increase expression of NDRG1 compared with isogenic wild-type controls and TP53 R248W knockin cells. Overexpression and RNA interference studies demonstrate that NDRG1 regulates centrosome number and amplification. Mechanistically, NDRG1 physically associates with γ-tubulin, a key component of the centrosome, with reduced association in p53 null cells. Strikingly, TP53 homozygous loss was mutually exclusive of NDRG1 overexpression in over 96% of human cancers, supporting the broad applicability of these results. Our study elucidates a mechanism of how TP53 loss leads to abnormal centrosome numbers and genomic instability mediated by NDRG1.

摘要

肿瘤蛋白53(TP53)肿瘤抑制基因是人类癌症中最常发生体细胞改变的基因。在此我们表明,在生理低增殖状态下,N - myc下调基因1(NDRG1)的表达由p53诱导,并介导中心体稳态,从而维持基因组稳定性。当置于生理低增殖条件下时,与同基因野生型对照和TP53 R248W敲入细胞相比,人TP53缺失细胞无法增加NDRG1的表达。过表达和RNA干扰研究表明,NDRG1调节中心体数量和扩增。从机制上讲,NDRG1与中心体的关键成分γ - 微管蛋白物理结合,在p53缺失细胞中的结合减少。引人注目的是,在超过96%的人类癌症中,TP53纯合缺失与NDRG1过表达相互排斥,这支持了这些结果的广泛适用性。我们的研究阐明了TP53缺失如何导致由NDRG1介导的中心体数量异常和基因组不稳定的机制。